Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 156

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 9C
Chunk 156
---
 ID 106)
    F-1

    Report of Independent Registered Public Accounting Firm (PCAOB Firm ID
42)
    F-2

    Balance Sheets as of December 31, 2024 and 2023
    F-3

    Statements of Operations for the years ended December 31, 2024 and 2023
    F-4

    Statement of Stockholders’ Equity (Deficit) for the years ended December 31, 2024 and 2023
    F-5

    Statements of Cash Flows for the years ended December 31, 2024 and 2023
    F-6

    Notes to Financial Statements
    F-8

Report
of Independent Registered Public Accounting Firm

To
the Stockholders and the Board of Directors of:

Telomir
Pharmaceuticals, Inc.

Opinion
on the Financial Statements

We have audited the accompanying balance sheet of Telomir Pharmaceuticals, Inc. (the “Company”) as of December 31, 2024, the
related statements of operations, changes in stockholders’ equity and cash flows for the year then ended, and the related notes
(collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all
material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows
for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

Going
Concern

The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note
2 to the financial statements, the Company raised approximately $6.9 million, used approximately $5.1 million of cash in operations and
had a net loss of $16.5 million during the year ended December 31, 2024. These matters raise substantial doubt about the Company’s
ability to continue as a going concern. Management’s Plans in regard to these matters are also described in Note 2. The financial
statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis
for Opinion

These
financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (“